Harry Herr

发表

Harry Herr, 2011, Urologic oncology.

Cisplatin, Neoadjuvant Chemotherapy and Bladder Cancer.

M. Soloway, Harry Herr, 2021, Urology.

J. Eastham, P. Sogani, Harry Herr, 2022, Journal of surgical oncology.

Feasibility of a geriatric comanagement (GERICO) pilot program for patients 75 and older undergoing radical cystectomy.

A. Vickers, B. Bochner, G. Nash, 2022, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Preoperative irradiation and cystectomy for bladder cancer

W. Whitmore, P. Sogani, H. Grabstald, 1982, Cancer.

Bladder preservation after neoadjuvant therapy - 2021 IBCN updates part 1.

G. Iyer, K. Mouw, L. Dyrskjøt, 2023, Urologic oncology.

Prospective Phase II Study to Evaluate Response to Two Induction Courses (12 intravesical instillations) of BCG Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer.

D. Sjoberg, G. Dalbagni, E. Vertosick, 2021, Urology.

Neoadjuvant Chemotherapy and Bladder-Sparing Surgery for Muscle-Invasive Bladder Cancer: Ten-year Outcomes.

Harry Herr, 2022, Urology.

Reduced Recurrence of Low-grade Papillary Bladder Tumors Associated With Asymptomatic Bacteriuria.

Machele Donat, Harry Herr, 2019, Urology.